In a rapidly changing world of innovation in Life Sciences the collective goal continues to be the improvement of patient outcomes but where investment is hard to secure, new geographies are gaining momentum and the policy backgrounds feel uncertain the chosen strategy from ideation to success can be difficult to plot. This session, kindly hosted by Mathys & Squire, will explore how innovators should be thinking about an effective IP strategy to enable them to harness the value of their inventions and innovation hence enabling them to secure the investment and deals necessary for translation. 
 
Agenda:
08.30 – Registration and Networking
09.15 – Welcome from Mathys & Squire & One Nucleus
09.25 – The Changing Landscape of Bio-Innovation
          Jessie You, V-P and Head of Business Development, PharmaVentures
09.40 – Deciding your IP strategy in uncertain times
          Craig Titmus, Partner & Martin Maclean, Partner, Mathys & Squire
09.55 – Case Study TBC 
10.10 – Panel Discussion with Speakers
10.40 – Networking & Close
 
Registration: 
This event is free to attend, invite only and is particularly aimed at attendees from:
•    Life Science R&D companies
•    TechBio companies
•    Tech Transfer Offices/Academia
•    Investors
•    CRO/CDMO companies

To request and invitation, please email Tony Jones directly.